Abstract:Objective Metabolic associated fatty liver disease (MAFLD) affects nearly a quarter of the world’s population. Our study aimed to characterize the gut microbiome and overall changes in the fecal and serum metabolomes in MAFLD patients. Methods Thirty-two patients diagnosed with MAFLD and 30 healthy individuals (control group, CG) were included in this study, the basic clinical characteristics and laboratory test results including routine biochemistry, etc. were recorded for all, and their serum and fecal samples were collected. A portion of the fecal samples was subjected to 16S rDNA sequencing, and the other portion of the fecal samples and serum samples were subjected to non-targeted metabolomic detection based on liquid chromatography-mass spectrometry (LC–MS). Statistical analysis of clinical data was performed using SPSS software package version 25.0 (SPSS Inc., Chicago, IL, United States). The analysis of 16S rDNA sequencing results was mainly performed by R software (V. 2.15.3), and the metabolomics data analysis was mainly performed by CD 3.1 software. Two-tailed p value < 0.05 was considered statistically significant. Results The 16S sequencing data suggested that the species richness and diversity of MAFLD patients were reduced compared with controls. At the phylum level, the relative abundance of Bacteroidota , Pseudomonadota , and Fusobacteriota increased and Bacillota decreased in MAFLD patients. At the genus level, the relative abundances of Prevotella , Bacteroides , Escherichia-Shigella , etc. increased. 2,770 metabolites were detected in stool samples and 1,245 metabolites were detected in serum samples. The proportion of differential lipid metabolites in serum (49%) was higher than that in feces (21%). There were 22 differential metabolites shared in feces and serum. And the association analysis indicated that LPC 18:0 was positively correlated with Christensenellaceae_R-7_group , Oscillospiraceae_UCG-002 ; neohesperidin was also positively correlated with Peptoniphilus , Phycicoccus , and Stomatobaculum . Conclusion Microbial sequencing data suggested decreased species richness and diversity and altered β-diversity in feces. Metabolomic analysis identified overall changes in fecal and serum metabolites dominated by lipid molecules. And the association analysis with gut microbes provided potentially pivotal gut microbiota-metabolite combinations in MAFLD patients, which might provide new clues for further research on the disease mechanism and the development of new diagnostic markers and treatments.

The impact of deleting the mitfa gene in zebrafish on the intestinal microbiota community

Low-dose Methylmercury Exposure Impairs the Locomotor Activity of Zebrafish: Role of Intestinal Inositol Metabolism.

Gut Microbiota and Phenotypic Changes Induced by Ablation of Liver- and Intestinal-Type Fatty Acid-Binding Proteins

The Function and the Affecting Factors of the Zebrafish Gut Microbiota

Gut bacteria <i>Vibrio</i> sp. and <i>Aeromonas</i> sp. trigger the expression levels of proinflammatory cytokine: First evidence from the germ-free zebrafish

Microbial Fingerprinting Detects Intestinal Microbiota Dysbiosis in Zebrafish Models with Chemically-Induced Enterocolitis

Deciphering the gut microbiota of zebrafish, the most used fish as a biological model: A meta-analytic approach

Effects of Inducible Nitric Oxide Synthase (iNOS) Gene Knockout on the Diversity, Composition, and Function of Gut Microbiota in Adult Zebrafish

Bacillus Licheniformis FA6 Affects Zebrafish Lipid Metabolism Through Promoting Acetyl-CoA Synthesis and Inhibiting Β-Oxidation.

Impact of gut microbiota on nonalcoholic fatty liver disease: insights from a leave-one-out cross-validation study

Effects of Antibiotic Residues on Fish Gut Microbiome Dysbiosis and Mucosal Barrier-Related Pathogen Susceptibility in Zebrafish Experimental Model

Sub-chronic exposure to antibiotics doxycycline, oxytetracycline or florfenicol impacts gut barrier and induces gut microbiota dysbiosis in adult zebrafish (Daino rerio)

Significant impairment of intestinal health in zebrafish after subchronic exposure to methylparaben

Role of gut microbiota in a zebrafish model with chemically induced enterocolitis involving toll-like receptor signaling pathways.

Transplantation of high fat fed mouse microbiota into zebrafish larvae identifies MyD88-dependent acceleration of hyperlipidaemia by Gram-positive cell wall components

Contribution of gut microbiota to hepatic steatosis following F-53B exposure from the perspective of glucose and fatty acid metabolism

Vitamin D influences gut microbiota and acetate production in zebrafish (Danio rerio) to promote intestinal immunity against invading pathogens

Analysis of Mutants from a Genetic Screening Reveals the Control of Intestine and Liver Development by Many Common Genes in Zebrafish.

Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patients

Comparative chronic toxicities of PFOS and its novel alternatives on the immune system associated with intestinal microbiota dysbiosis in adult zebrafish

16S rRNA gene-based association study identified microbial taxa associated with pork intramuscular fat content in feces and cecum lumen